Transcultural Validation of MSTS and TESS Questionnaire
Launched by NANTES UNIVERSITY HOSPITAL · Dec 4, 2018
Trial Information
Current as of May 24, 2025
Unknown status
Keywords
ClinConnect Summary
The methodology will follow the guidelines of Dorcas E. Beaton, Claire Bombardier, Francis Guillemin and Marcos Bosi Ferraz (approved in particular by the American Academy of Orthopedic Surgeons):
Step 1: Author's agreement Step 2: Translation with cultural adaptation in addition to literal translation Step 3: 2 first translations English to French (2 different translators T1 and T2) Step 4: Synthesis (T12) Step 5: 2 reverse translations of T12 French to English (BT1 and BT2) Step 6: Submission to a committee of experts of the final translation Step 7: Clinical study based on a sample of p...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Major Patients who has accepted and be informed of the protocol or minor patient over 15 years old who has accepted and be informed of the protocol, with the agreement of one legal representative
- • Patients over 15 years old who had a surgical procedure for a musculoskeletal tumor which could result in functional sequels. (at the appreciation of the surgeon)
- • Patients in the capacity to answer and understand the questionnaire and for whom the French is the native language
- Exclusion Criteria:
- • Patients refusing to participate
- • Patient under guardianship
- • Patient inappropriate for entry into this study according to the judgment of the investigator
About Nantes University Hospital
Nantes University Hospital, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific exploration with patient care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Nantes University Hospital aims to contribute to the development of effective therapies and interventions that enhance patient outcomes and overall public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nantes, , France
Rennes, , France
Tours, , France
Marseille, , France
Patients applied
Trial Officials
Kevin BRULEFERT, Dr
Principal Investigator
Nantes University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials